Trial Outcomes & Findings for Study to Identify Factors Influencing Access of Pregnant Women and Their Infants to Local Healthcare Systems (NCT NCT01734434)

NCT ID: NCT01734434

Last Updated: 2018-12-11

Results Overview

The percentage of subjects who delivered at the study site relative to the number of enrolled subjects was calculated

Recruitment status

COMPLETED

Target enrollment

3243 participants

Primary outcome timeframe

Baseline until average of 24 weeks

Results posted on

2018-12-11

Participant Flow

Subjects were enrolled at Dominican Republic, Panama, Mozambique, and South Africa.

All enrolled subjects were included in the trial.

Participant milestones

Participant milestones
Measure
Maternal Subjects (Dominican Republic)
Pregnant women who were enrolled in Dominican Republic.
Maternal Subjects (Panama)
Pregnant women who were enrolled in Panama.
Maternal Subjects (South Africa)
Pregnant women who were enrolled in South Africa.
Maternal Subjects (Mozambique)
Pregnant women who were enrolled in Mozambique.
Overall Study
STARTED
500
500
1992
251
Overall Study
COMPLETED
490
488
1863
228
Overall Study
NOT COMPLETED
10
12
129
23

Reasons for withdrawal

Reasons for withdrawal
Measure
Maternal Subjects (Dominican Republic)
Pregnant women who were enrolled in Dominican Republic.
Maternal Subjects (Panama)
Pregnant women who were enrolled in Panama.
Maternal Subjects (South Africa)
Pregnant women who were enrolled in South Africa.
Maternal Subjects (Mozambique)
Pregnant women who were enrolled in Mozambique.
Overall Study
Death Infant
3
1
17
5
Overall Study
Lost to Follow-up
2
9
67
11
Overall Study
No Live Birth
1
2
32
6
Overall Study
Withdrawal by Subject
4
0
8
1
Overall Study
Signed Adult Version of Consent Form
0
0
1
0
Overall Study
Subject Not Reachable
0
0
1
0
Overall Study
Treatment Defaulter
0
0
1
0
Overall Study
Wrong Version of Consent Form Signed
0
0
1
0
Overall Study
17 Yr Old Subject Signed Consent form
0
0
1
0

Baseline Characteristics

Study to Identify Factors Influencing Access of Pregnant Women and Their Infants to Local Healthcare Systems

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Maternal Subjects (Dominican Republic)
n=500 Participants
Pregnant women who were enrolled in Dominican Republic.
Maternal Subjects (Panama)
n=500 Participants
Pregnant women who were enrolled in Panama.
Maternal Subjects (South Africa)
n=1989 Participants
Pregnant women who were enrolled in South Africa.
Maternal Subjects (Mozambique)
n=251 Participants
Pregnant women who were enrolled in Mozambique.
Total
n=3240 Participants
Total of all reporting groups
Age, Continuous
24.49 Years
STANDARD_DEVIATION 5.28 • n=5 Participants
25.08 Years
STANDARD_DEVIATION 5.65 • n=7 Participants
27.05 Years
STANDARD_DEVIATION 6.05 • n=5 Participants
25.01 Years
STANDARD_DEVIATION 6.26 • n=4 Participants
26.19 Years
STANDARD_DEVIATION 5.99 • n=21 Participants
Sex: Female, Male
Female
500 Participants
n=5 Participants
500 Participants
n=7 Participants
1989 Participants
n=5 Participants
251 Participants
n=4 Participants
3240 Participants
n=21 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants

PRIMARY outcome

Timeframe: Baseline until average of 24 weeks

Population: Analysis was done on Full analysis set (FAS)-All subjects in the All Enrolled Set who provided data after enrollment related to delivery, logistics or medical outcomes.

The percentage of subjects who delivered at the study site relative to the number of enrolled subjects was calculated

Outcome measures

Outcome measures
Measure
Maternal Subjects (Dominican Republic)
n=500 Participants
Pregnant women who were enrolled in Dominican Republic.
Maternal Subjects (Panama)
n=500 Participants
Pregnant women who were enrolled in Panama.
Maternal Subjects (South Africa)
n=1989 Participants
Pregnant women who were enrolled in South Africa.
Maternal Subjects (Mozambique)
n=251 Participants
Pregnant women who were enrolled in Mozambique.
Percentage of Subjects Delivering at a Study Site.
Subjects with known delivery information
99.20 Percentages of subjects
Interval 97.96 to 99.78
100 Percentages of subjects
Interval 99.26 to 100.0
99.65 Percentages of subjects
Interval 99.28 to 99.86
100 Percentages of subjects
Interval 98.54 to 100.0
Percentage of Subjects Delivering at a Study Site.
Study site delivery
68.55 Percentages of subjects
Interval 64.26 to 72.61
74.40 Percentages of subjects
Interval 70.34 to 78.17
56.66 Percentages of subjects
Interval 54.44 to 58.86
86.85 Percentages of subjects
Interval 82.03 to 90.77

PRIMARY outcome

Timeframe: Baseline until average of 24 weeks

Population: Analysis was done on FAS.

The percentage of subjects who delivered at a non-study site relative to the number of enrolled subjects was calculated.

Outcome measures

Outcome measures
Measure
Maternal Subjects (Dominican Republic)
n=500 Participants
Pregnant women who were enrolled in Dominican Republic.
Maternal Subjects (Panama)
n=500 Participants
Pregnant women who were enrolled in Panama.
Maternal Subjects (South Africa)
n=1989 Participants
Pregnant women who were enrolled in South Africa.
Maternal Subjects (Mozambique)
n=251 Participants
Pregnant women who were enrolled in Mozambique.
Percentage of Subjects Delivering at a Non-study Site.
Subjects with known delivery information
99.20 Percentages of subjects
Interval 97.96 to 99.78
100 Percentages of subjects
Interval 99.26 to 100.0
99.65 Percentages of subjects
Interval 99.28 to 99.86
100 Percentages of subjects
Interval 98.54 to 100.0
Percentage of Subjects Delivering at a Non-study Site.
Non-study healthcare facility
30.85 Percentages of subjects
Interval 26.81 to 35.12
24.60 Percentages of subjects
Interval 20.88 to 28.62
41.32 Percentages of subjects
Interval 39.14 to 43.53
7.97 Percentages of subjects
Interval 4.93 to 12.04
Percentage of Subjects Delivering at a Non-study Site.
Home
0 Percentages of subjects
Interval 0.0 to 0.0
0.40 Percentages of subjects
Interval 0.05 to 1.44
0.76 Percentages of subjects
Interval 0.42 to 1.25
2.79 Percentages of subjects
Interval 1.13 to 5.66
Percentage of Subjects Delivering at a Non-study Site.
Other
0 Percentages of subjects
Interval 0.0 to 0.0
0 Percentages of subjects
Interval 0.0 to 0.0
0.50 Percentages of subjects
Interval 0.24 to 0.93
0.40 Percentages of subjects
Interval 0.01 to 2.2
Percentage of Subjects Delivering at a Non-study Site.
Unknown
0.60 Percentages of subjects
Interval 0.12 to 1.76
0.60 Percentages of subjects
Interval 0.12 to 1.74
0.76 Percentages of subjects
Interval 0.42 to 1.25
1.99 Percentages of subjects
Interval 0.65 to 4.59

SECONDARY outcome

Timeframe: Delivery to Day 90 post-delivery (Infant follow-up)

Population: Analysis was done on the FAS

The number of infants born live, reported sick and brought to a study or non-study health care facility site by the maternal subjects over the period of 90 days after delivery was calculated.

Outcome measures

Outcome measures
Measure
Maternal Subjects (Dominican Republic)
n=493 Participants
Pregnant women who were enrolled in Dominican Republic.
Maternal Subjects (Panama)
n=498 Participants
Pregnant women who were enrolled in Panama.
Maternal Subjects (South Africa)
n=1966 Participants
Pregnant women who were enrolled in South Africa.
Maternal Subjects (Mozambique)
n=242 Participants
Pregnant women who were enrolled in Mozambique.
Number of Infants Born Live, Reported Sick and Brought to a Study or Non-study Health Care Facility Site.
Live births at discharge
493 participants
498 participants
1966 participants
242 participants
Number of Infants Born Live, Reported Sick and Brought to a Study or Non-study Health Care Facility Site.
Infants reported sick
58 participants
81 participants
74 participants
5 participants
Number of Infants Born Live, Reported Sick and Brought to a Study or Non-study Health Care Facility Site.
Infants brought to health care facility-study site
54 participants
147 participants
27 participants
51 participants

SECONDARY outcome

Timeframe: Delivery to Day 90 post-delivery (Infant follow-up)

Population: Analysis was performed on the FAS.

The number of infants who were brought by the maternal subjects to a study site for 90-day infant follow-up visit relative to the number of live birth deliveries.

Outcome measures

Outcome measures
Measure
Maternal Subjects (Dominican Republic)
n=493 Participants
Pregnant women who were enrolled in Dominican Republic.
Maternal Subjects (Panama)
n=498 Participants
Pregnant women who were enrolled in Panama.
Maternal Subjects (South Africa)
n=1966 Participants
Pregnant women who were enrolled in South Africa.
Maternal Subjects (Mozambique)
n=242 Participants
Pregnant women who were enrolled in Mozambique.
Number of Infants Brought to Study Site During Infant Follow up (90 Days Post-delivery)
479 participants
333 participants
1163 participants
146 participants

Adverse Events

Maternal Subjects (Dominican Republic)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Maternal Subjects (Panama)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Maternal Subjects (South Africa)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Maternal Subjects (Mozambique)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Posting Director

Novartis Vaccines and Diagnostics

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60